Xorte logo

News Markets Groups

USA | Europe | Asia | World| Stocks | Commodities



Add a new RSS channel

 
 


Keywords

2025-08-19 04:10:29| The Economic Times

Chandrima Mercantiles, a multibagger stock, is undergoing a stock split. The face value is changing from Rs 10 to Rs 1. August 20 is the record date. Today is the last day to buy shares to qualify. The split aims to improve liquidity and accessibility. The stock has delivered nearly 700% returns in two years.


Category: News and Media

 

LATEST NEWS

2025-08-19 04:06:02| BBC News | Business | World Edition

The announcement comes hours after reports that the White House is in talks over taking a 10% stake in Intel.


Category: News and Media

 

2025-08-19 02:39:45| BBC News | Business | World Edition

The announcement comes hours after reports that the White House is in talks over taking a 10% stake in Intel.


Category: News and Media

 

Latest from this category

22.08Revolution Beauty to 'reset' after sale falls through
22.08The shop making people laugh for nearly 100 years
22.08As CTA tax district rakes in huge amount of taxpayer money, decision looms over what to do with it
22.08Child benefit: What is it worth and who can claim it?
22.08Right time to take profit off the table in pharma; defence a structural buy: Rajiv Batra
22.08'I work full-time but can't afford school uniform'
22.08Private Chinese firm producing oil in Venezuela under rare 20-year pact, source says
22.08Fed officials divided ahead of Powells Jackson Hole Speech
News and Media »

All news

22.08Revolution Beauty to 'reset' after sale falls through
22.08The shop making people laugh for nearly 100 years
22.08As CTA tax district rakes in huge amount of taxpayer money, decision looms over what to do with it
22.08Child benefit: What is it worth and who can claim it?
22.08This startup claims it just outran Nvidia on its own turf
22.08Most toothpaste tubes are recyclable. So why is nobody recycling them?
22.08Fear is paralyzing innovation. Heres how to fix it
22.08Right time to take profit off the table in pharma; defence a structural buy: Rajiv Batra
More »
Privacy policy . Copyright . Contact form .